MA

Madhu Agrawal

Active Director Director DIN 00836730
DIN 00836730 First appointment Jun 1989 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 1989
Shareholding value •••• Premium profile

About Madhu Agrawal

Data last updated:

Madhu Agrawal is a Director at Mansfield Laboratories Private Limited (since 1989). The company operates in Pharma. Mansfield Laboratories Private Limited reported revenue of ₹5.8 Lakh (FY 2017).

DIN 00836730
Primary Designation Director
Industry Pharma
First Appointment 01 Jun 1989
Oldest Company Age 37 yrs
Largest company Mansfield Laboratories Private Limited · ₹5.8 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 19891989₹5.8 Lakh (FY 2017)Active

Board colleagues of Madhu Agrawal

Directorship timeline

Open interactive timeline →
Mansfield Laboratories Private Limited
Premium access

Shareholding and investment profile for Madhu Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhu Agrawal

Madhu Agrawal currently holds 1 directorship: Mansfield Laboratories Private Limited (Director, since 01 Jun 1989, revenue ₹5.8 Lakh (FY 2017)).

Madhu Agrawal was first appointed on 01 Jun 1989 as Director at Mansfield Laboratories Private Limited.

The current boards of Madhu Agrawal's companies include Alok Krishna Agarwal (Mansfield Laboratories Private Limited), Anupriya Agrawal (Mansfield Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available